World's Best Scientists 2026 revealed!
Gilles R. Dagenais

Gilles R. Dagenais

D-Index & Metrics

Medicine

D-Index
107
Citations
71489
World Ranking
6100
National Ranking
235

Gilles R. Dagenais publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gilles R. Dagenais sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 341 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gilles R. Dagenais D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gilles R. Dagenais sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gilles R. Dagenais is affiliated with Université Laval in Canada and has a significant presence in the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine. Their work spans multiple subfields including Economics and Econometrics, Endocrinology, Diabetes and Metabolism, General Health Professions, and Internal Medicine.

The primary research topics covered in their body of work include:

  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Venous Thromboembolism Diagnosis and Management
  • Blood Pressure and Hypertension Studies
  • Metabolism, Diabetes, and Cancer

Gilles R. Dagenais has published extensively across various scientific journals, with frequent contributions to:

  • European Heart Journal
  • Circulation
  • Cardiovascular Research
  • Cardiovascular Diabetology
  • Stroke

Some recent papers illustrate the scope and focus of their research. These include:

  • "Polypill with or without Aspirin in Persons without Cardiovascular Disease" (2020) in New England Journal of Medicine
  • "The household economic burden of non-communicable diseases in 18 countries" (2020) in BMJ Global Health
  • "Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease" (2020) in Circulation
  • "Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis" (2021) in The Lancet
  • "Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries" (2021) in JAMA Internal Medicine

The scientist collaborates frequently with a core group of co-authors, including Salim Yusuf, Patricio López-Jaramillo, Jackie Bosch, Álvaro Avezum, and Jeffrey L. Probstfield. These collaborations reflect a broad engagement in cardiovascular and metabolic research.

Best Publications

  • Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

    Koon K. Teo;Janice Pogue;Leanne Dyal;Ingrid Copland

  • The effect of digoxin on mortality and morbidity in patients with heart failure

    G Perry;E Brown;R Thornton;T Shiva

  • Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease

    Jean-Pierre Després;Benoît Lamarche;Pascale Mauriège;Bernard Cantin

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

    Clara K. Chow;Clara K. Chow;Koon K. Teo;Sumathy Rangarajan;Shofiqul Islam

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

    Salim Yusuf;Philip Joseph;Sumathy Rangarajan;Shofiqul Islam

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    J Danesh;S Lewington;S G Thompson;Lowe Gdo.

  • Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

    B Lamarche;A Tchernof;S Moorjani;B Cantin

  • Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

    Eva Lonn;Jackie Bosch;Salim Yusuf;Patrick Sheridan

  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

    Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood

  • Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

    Mahshid Dehghan;Andrew Mente;Andrew Mente;Xiaohe Zhang;Sumathi Swaminathan

  • Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

    M St John Sutton;M A Pfeffer;T Plappert;J L Rouleau

  • Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

    Salim Yusuf;Shofiqul Islam;Clara K Chow;Sumathy Rangarajan

  • World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

    Stephen Kaptoge;Lisa Pennells;Dirk De Bacquer;Marie Therese Cooney

  • Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

    Salim Yusuf;Sumathy Rangarajan;Koon Teo;Shofiqul Islam

  • Effect of ramipril on the incidence of diabetes.

    Jackie Bosch;Salim Yusuf;Hertzel C Gerstein

  • Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

    Andrew Mente;Sumathy Rangarajan;Matthew J. McQueen;Xingyu Wang

  • Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Salim Yusuf;Jackie Bosch;Gilles Dagenais;Jun Zhu

  • Association of Cardiometabolic Multimorbidity With Mortality

    Emanuele Di Angelantonio;Stephen Kaptoge;David Wormser;Peter Willeit

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Alvaro Avezum
Alvaro Avezum Population Health Research Institute
Koon K. Teo
Koon K. Teo McMaster University
Patricio López-Jaramillo
Patricio López-Jaramillo University of Santander
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Rafael Diaz
Rafael Diaz University of Alberta
Eva Lonn
Eva Lonn McMaster University
Jackie Bosch
Jackie Bosch McMaster University
Annika Rosengren
Annika Rosengren Sahlgrenska University Hospital
Jean-Pierre Després
Jean-Pierre Després Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine, exploring online healthcare degrees can open diverse career pathways. Many students today seek flexible learning options, and accredited programs ensure quality education and better job prospects.

If you aim for leadership roles in healthcare, consider enrolling in accredited mha programs to develop management skills and broaden your career scope. Registered nurses looking to advance their credentials may opt for specialized rn to bsn programs no clinicals that offer academic progression without the need for additional clinical hours.

For those already holding a master’s in nursing, the shortest msn to dnp program options provide an efficient route to the highest level of clinical nursing practice. If you seek less intensive coursework, you can review the easiest online dnp programs to find the most accessible path toward advanced nursing roles.

These online pathways can help you upskill or switch careers, making advanced degrees accessible no matter your current life situation.

Best Scientists Citing Gilles R. Dagenais

Trending Scientists

Recently Published Articles